Mr. Mark Stortz reports

CRESCO LABS APPOINTS EDWARD TILLY TO BOARD OF DIRECTORS

Cresco Labs Inc. has appointed Edward Tilly to its board of directors, effective Sept. 18, 2026. Mr. Tilly will serve as an independent director and join the audit committee, bringing the board to eight directors.

Mr. Tilly is a financial markets executive with more than 35 years of experience spanning exchange operations, market structure, capital markets and global regulatory engagement. He served as chairman and chief executive officer of Cboe Global Markets for a decade, helping transform the company from a domestic options exchange into a diversified global market infrastructure operator, growing its market capitalization from approximately $2-billion (U.S.) to more than $18-billion (U.S.). During his tenure, he led Cboe's $3.4-billion (U.S.) acquisition of Bats Global Markets and expanded the company's operational footprint to six continents.

He served as chairman of the World Federation of Exchanges from 2021 to 2023 and has held board seats at the Options Clearing Corp. and the National Stock Exchange. Most recently, he was chief executive officer of Clear Street, a prime brokerage and financial infrastructure firm, and continues to serve on its board of directors.

"Ed has spent his career building and governing the infrastructure that public markets run on," said Tom Manning, chairman of Cresco Labs' board. "As the federal landscape evolves and U.S. capital markets access opens to companies like ours, few people better understand how to navigate the strategic and financial opportunities ahead. That perspective is exactly what we want in our boardroom as we prepare for the next stage of Cresco's growth."

"Cresco has built a leading branded portfolio in U.S. cannabis and a retail platform that consistently outperforms its markets," said Mr. Tilly. "That operating foundation positions the company well as access to U.S. capital markets broadens. I look forward to working with the board and management team to help Cresco capitalize on the opportunities ahead."

About Cresco Labs Inc.

Cresco Labs' mission is to normalize and professionalize the cannabis industry through a CPG (consumer packaged goods) approach to building national brands and a customer-focused retail experience, while acting as a steward for the industry on legislative and regulatory-focused initiatives. As a leader in cultivation, production and branded product distribution, the company is leveraging its scale and agility to grow its portfolio of brands, including Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindy's and Remedi, on a national level. The company also operates highly productive dispensaries nationally under the Sunnyside brand that focus on building patient and consumer trust and delivering continuing education and convenience in a wonderfully traditional retail experience. Through year-round policy, community outreach and SEED (social equity and educational development) initiative efforts, Cresco Labs embraces the responsibility to support communities through authentic engagement, economic opportunity, investment, work force development and legislative initiatives designed to create the most responsible, respectable and robust cannabis industry possible.

We seek Safe Harbor.